4//SEC Filing
Georgantas Robert William III 4
Accession 0001140361-22-041081
CIK 0001439725other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 9:02 PM ET
Size
13.9 KB
Accession
0001140361-22-041081
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Georgantas Robert William III
DirectorSVP, Rsrch & Trans'l Science
Transactions
- Exercise/Conversion
Common Stock
2022-11-08+5,646→ 27,890 total - Sale
Common Stock
2022-11-10$1.02/sh−785$799→ 26,114 total - Sale
Common Stock
2022-11-09$1.04/sh−991$1,032→ 26,899 total - Exercise/Conversion
Restricted Stock Units
2022-11-08−3,676→ 11,026 total→ Common Stock (3,676 underlying) - Exercise/Conversion
Restricted Stock Units
2022-11-08−1,970→ 25,624 total→ Common Stock (1,970 underlying)
Holdings
- 100(indirect: By UGMA Account)
Common Stock
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").
- [F2]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
- [F3]These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
- [F4]These Shares were sold automatically to cover taxes upon the vesting of RSUs.
- [F5]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001827728
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 9:02 PM ET
- Size
- 13.9 KB